Poudre insecticide anti punaise de lit — recall SR/00924/25
EU Safety Gate (RAPEX) · France · 2025-03-14 · Serious risk
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: L'étiquetage du produit n'inclut pas les informations de danger et d'avertissement appropriées. L'emballage du produit n'est pas équipé d'une fermeture résistante aux enfants ni d'un avertissement tactile de danger. L'utilisateur manque donc des informations nécessaires sur les dangers si le produit entre en contact avec la peau ou s'il est ingéré. Le produit n'est pas conforme au règlement sur la classification, l'étiquetage et l'emballage des substances et des mélanges (CLP).
Action taken by the authority
Type of economic operator taking notified measure
Distributor
Category of measure
Withdrawal of the product from the market
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): Poudre insecticide anti punaise de lit
Risk Description (original English): The labelling on the product does not include the appropriate hazard and warning information. The product packaging is not equipped with a child-resistant fastening nor with a tactile warning of danger. The user therefore lacks the necessary information about the dangers if the product comes into contact with the skin or if it is ingested.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.